| - SMTL ID
- 5o3b.1
- Ligands
- methyl (2~{R})-2-[(4~{S})-6-(4-chlorophenyl)-8-methoxy-1-methyl-4~{H}-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]pent-4-enoate
- Polypeptides
- Bromodomain-containing protein 2
- Oligo-state
- monomer
|
| - SMTL ID
- 5o3b.2
- Ligands
- methyl (2~{R})-2-[(4~{S})-6-(4-chlorophenyl)-8-methoxy-1-methyl-4~{H}-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]pent-4-enoate
- Polypeptides
- Bromodomain-containing protein 2
- Oligo-state
- monomer
|
| - SMTL ID
- 5o3b.3
- Ligands
- methyl (2~{R})-2-[(4~{S})-6-(4-chlorophenyl)-8-methoxy-1-methyl-4~{H}-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]pent-4-enoate
- Polypeptides
- Bromodomain-containing protein 2
- Oligo-state
- monomer
|
| - SMTL ID
- 5o3b.4
- Ligands
- methyl (2~{R})-2-[(4~{S})-6-(4-chlorophenyl)-8-methoxy-1-methyl-4~{H}-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]pent-4-enoate
- Polypeptides
- Bromodomain-containing protein 2
- Oligo-state
- monomer
|